Top 10 Mental Health Companies Revolutionising Healthcare in the UK | 2025
In the years since the pandemic, mental health has remained firmly at the forefront of public and corporate awareness. The lasting effects of lockdowns, isolation, and workplace stress have driven an ongoing focus on wellbeing, both at an individual and organisational level.
In this article, we highlight 10 of the UK’s most promising mental health and wellbeing companies, each transforming how care is delivered, accessed, and experienced.
The UK’s mental health landscape at a glance
According to our data, there are 5,898 active mental health-focussed companies in the UK. Together, these companies have raised £1.86b in equity investment since 2011, with an average raise of £1.79m.
Funding in the sector surged in 2021, reaching £448m across 155 fundraisings, followed by a further £284m in 2022. Funding dropped in 2023 to £225m but grew again in 2024 up to £266m. So far in 2025, there’s been £215m invested into mental health care companies, and with two months left of the year, it’s hard to predict if this will be more or less than 2024.
Most of the companies that have received funding are headquartered in London (1,462), followed by the South East (825) and North West (610), though innovative startups are emerging across every region.
The largest areas of focus for mental health startups include psychiatry, psychotherapy, and counselling (31.3%), application software (25.0%), care homes (17.9%), and homecare (16.9%), which illustrates how digital and in-person care are increasingly blending to meet growing demand.
Top 10 UK Healthtech Companies | 2025
Explore the rise of UK healthtech companies and the influence of the COVID-19 pandemic on the digital transformation of healthcare services.
The top 10 mental health companies in the UK
Companies have been ranked by total equity and loan funding raised.
Togetherall
Total amount raised: £17.0m
Total equity rounds: 7
Established: 2018
Location: London
Togetherall has developed an online community where users can anonymously post about their problems and concerns and get help from professional counsellors. The website also provides tools to measure your wellbeing and online self-help courses.
This Camden-based company has been through seven funding rounds and raised a total of £17.0m. It attended the Mayor’s International Business Programme accelerator programme, and has hit the Beauhurst Signal for 10% Scaleup, meaning it’s scaled up by at least 10% over three consecutive years.
Healios
Total amount raised: £29.1m
Total equity rounds: 7
Established: 2013
Location: London
Healios provides families of sufferers of mental health issues with technology and training to care for their relatives at home, as well as providing direct support to patients.
Established in 2013, the company has been through seven funding rounds and received a grant of £49.6k from InnovateUK as part of the Mental Health Clinical Delivery Platform project. The company has also been featured on two high-growth lists: the BusinessCloud MedTech 50 in 2021, and the Top 200 Women-Powered Businesses in 2023.
Peppy
Total amount raised: £46.4m
Total equity rounds: 4
Established: 2018
Location: London
Peppy is transforming how employers support their workforce’s health by offering accessible, specialist care in underserved areas such as fertility, menopause, and early parenthood, as well as specialised emotional wellbeing support for men and women.
Founded in 2018, Peppy has become one of the UK’s standout healthtech success stories, raising £46.4m across multiple funding rounds from investors including AlbionVC, Felix Capital, Seedcamp, and Sony Innovation Fund. The company’s rapid expansion and impact have seen it feature on numerous high-growth lists, including The Sunday Times Tech 100 (2025) and LinkedIn Top Startups UK.
HealthHero
Total amount raised: £50.3m
Total equity rounds: 1
Established: 2019
Location: London
HealthHero creates digital solutions that make healthcare more accessible through remote consultations, virtual triage, and clinical support. It also offers in-app tips and tools to improve your mental health and wellbeing. Founded in 2019, HealthHero has quickly become one of Europe’s largest telehealth providers, securing £50.3m in venture funding from MARCOL and expanding rapidly through a series of strategic acquisitions. These include DoctorLink in the UK, MyClinic in Ireland, and Qare in France.
Recognised on The Sunday Times Tech 100 (2025) and BusinessCloud’s HealthTech 50, HealthHero continues to play a key role in shaping modern healthcare delivery.
ieso
Total amount raised: £67.4m
Total equity rounds: 8
Established: 2015
Location: Cambridge
ieso (formerly PsychologyOnline) delivers clinically proven online cognitive behavioural therapy (CBT) for people experiencing depression, anxiety, and related mental health conditions.
Since its rebrand in 2015, ieso has grown into one of the UK’s leading digital mental health providers, securing over £67m in funding from investors including Molten Ventures, IP Group, Morningside Ventures, Sony Innovation Fund, and Ananda Impact Ventures. The company’s platform has supported tens of thousands of patients and contributed valuable research into digital therapy efficacy.
In 2025, ieso was acquired by Swedish mental health company Mindler, marking a major step in expanding its digital therapy capabilities across Europe.
Unmind
Total amount raised: £102m
Total equity rounds: 9
Established: 2016
Location: London
Unmind is a workplace mental health platform that helps organisations measure, understand, and improve employee wellbeing at scale. Its app combines self-guided tools, personalised content, and expert-led training to support mental health, resilience, and performance across global teams.
Since its launch, Unmind has raised £102m across multiple funding rounds from investors including EQT Ventures, Felix Capital, Project A, Sapphire Ventures, and True Ventures. The company has also made strategic moves to broaden its offering, most notably through its acquisition of Ireland-based Frankie Health in 2023.
Beckley Psytech
Total amount raised: £107m
Total equity rounds: 4
Established: 2018
Location: Oxford
Beckley Psytech is pioneering research into psychedelic-assisted therapies, with a focus on the compound 5-MeO-DMT as a potential treatment for mental health conditions including depression and addiction.
Founded in partnership with the Beckley Foundation, Beckley Psytech has raised £107m from a global network of investors including ATAI Life Sciences, Prime Movers Lab, Adage Capital Management, and Negev Capital. The company further strengthened its position in the psychedelic medicine space through its acquisition of Eleusis in 2022, expanding its research and development pipeline.
Meallmore
Total amount raised: £107m
Total equity rounds: 3
Established: 1987
Location: Inverness
Meallmore provides residential care and nursing care, operating 26 homes across Scotland. With over three decades of experience, the company delivers care for elderly people and those living with complex health conditions, such as dementia and mental health needs.
The company has raised £107m in loan funding, including recent backing from HSBC Commercial Banking and Allied Irish Bank, to support ongoing investment in its homes and facilities.
YuLife
Total amount raised: £164m
Total equity rounds: 4
Established: 2016
Location: London
YuLife develops a digital insurance platform that blends life insurance, wellbeing, and rewards. By gamifying healthy habits such as walking, meditation, and cycling, YuLife encourages users to prioritise physical and mental wellbeing — earning rewards from popular brands in return.
Founded in 2016, YuLife has grown rapidly, raising over £164m from investors including Anthemis, Creandum, Eurazeo, Latitude, MMC Ventures, Notion Capital, OurCrowd, and Target Global. In 2024, the company also received a £156k Innovate UK grant to further develop its technology and services.
COMPASS Pathways
Total amount raised: £237m
Total equity rounds: 7
Established: 2017
Location: London
COMPASS Pathways is a mental healthcare company pioneering the use of psilocybin-based therapies to treat conditions such as depression.
Founded in 2017, COMPASS has raised over £237m through private and public investment, including a £113m IPO in 2020. Key investors include ATAI Life Sciences, RA Capital, Founders Fund, Deep Track Capital, and Vivo Capital. Its lead programme is focused on the development of COMP360 psilocybin therapy, currently being evaluated in clinical trials across multiple countries.
Working with Beauhurst
If you’re interested in exploring the UK’s growing mental health sector, Beauhurst can help. Through our platform, you can identify emerging frontrunners and analyse companies with high growth potential at every stage.
Our data provides a complete view of the market, from investment trends and regional activity to sector-specific breakdowns, helping you make informed decisions with confidence.
Book a demo to find out how Beauhurst can support your next move.
Discover our data.
Get access to unrivalled data on the companies you need to know about, so you can approach the right leads, at the right time.
Schedule a conversation today to see all of the key features of the Beauhurst platform, as well as the depth and breadth of data available.
We’ll work with you to build a sophisticated search, returning a dynamic list of organisations that match your ideal customer profile.
Beauhurst Privacy Policy